(Q40373234)

19 September 2017

title

Calcific aortic stenosis: medical and surgical management in the elderly (English)

1 reference

19 September 2017

0 references

1 reference

Nalini M Rajamannan

1

1 reference

19 September 2017

publication date

1 December 2005

1 reference

Current treatment options in cardiovascular medicine

19 September 2017

published in

1 reference

19 September 2017

volume

7

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

437-442

1 reference

https://scigraph.springernature.com/pub.10.1007/s11936-005-0028-9

19 September 2017

exact match

0 references

cites work

Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-005-0028-9

Prediction of Coronary Heart Disease Using Risk Factor Categories

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-005-0028-9

New insights into the progression of aortic stenosis: implications for secondary prevention.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11936-005-0028-9

Development of aortic valve sclerosis in a rabbit model of atherosclerosis: an immunohistochemical and histological study.

21 January 2018

1 reference

12 December 2020

Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular

1 reference

12 December 2020

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis

1 reference

12 December 2020

Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function

1 reference

12 December 2020

Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up

1 reference

12 December 2020

HMG CoA reductase inhibitor (statin) and aortic valve calcium

1 reference

12 December 2020

Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves

1 reference

12 December 2020

Experimental aortic valve stenosis in rabbits

1 reference

12 December 2020

Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis

1 reference

12 December 2020

1 reference

12 December 2020

Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve

1 reference

12 December 2020

Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis

1 reference

12 December 2020

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis

1 reference

12 December 2020

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study

1 reference

12 December 2020

Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve

1 reference

12 December 2020

The epidemiology of valvular heart diseases: the problem is growing

1 reference

12 December 2020

Surface responses of aortic valve endothelia from diet-induced, hypercholesterolemic rabbits

1 reference

12 December 2020

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 199

1 reference

12 December 2020

Association between calcific aortic stenosis and hypercholesterolemia: is there a need for a randomized controlled trial of cholesterol-lowering therapy?

1 reference

12 December 2020

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community

1 reference

12 December 2020

Worldwide perspective of valve disease

1 reference

12 December 2020

Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons

1 reference

12 December 2020

Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma

1 reference

12 December 2020

Osteopontin is expressed in human aortic valvular lesions

1 reference

12 December 2020

Rheumatic heart disease: prevalence and preventive measures in the Indian subcontinent. Keywords: rheumatic heart disease; rheumatic fever

1 reference

12 December 2020

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve

1 reference

12 December 2020

Experimental hypercholesterolemia induces apoptosis in the aortic valve.

1 reference

12 December 2020

Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors

1 reference

12 December 2020

Detection of osteopontin in calcified human aortic valves

1 reference

12 December 2020

10.1007/S11936-005-0028-9

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1009307054

0 references

1 reference